Literature DB >> 1634111

Mapping of a region of dengue virus type-2 glycoprotein required for binding by a neutralizing monoclonal antibody.

T Trirawatanapong1, B Chandran, R Putnak, R Padmanabhan.   

Abstract

Envelope glycoprotein E of flaviviruses is exposed at the surface of the virion, and is responsible for eliciting a neutralizing antibody (Ab) response, as well as protective immunity in the host. In this report, we describe a method for the fine mapping of a linear sequence of the E protein of dengue virus type-2 (DEN-2), recognized by a type-specific and neutralizing monoclonal Ab (mAb), 3H5. First, an Escherichia coli expression vector containing a heat-inducible lambda pL promoter was used to synthesize several truncated, and near-full length E polypeptides. Reactivities of these polypeptides with polyclonal mouse hyperimmune sera, as well as the 3H5 mAb revealed the location of the 3H5-binding site to be within a region of 166 amino acids (aa) between aa 255 and 422. For fine mapping, a series of targeted deletions were made inframe within this region using the polymerase chain reaction (PCR). The hydrophilicity pattern of this region was used as a guide to systematically delete the regions encoding the various groups of surface aa residues within the context of a near-full-length E polypeptide by using PCR. The 3H5-binding site was thus precisely mapped to a region encoding 12 aa (between aa 386 and 397). A synthetic peptide containing this sequence was able to bind to the 3H5 mAb specifically, as shown by enzyme-linked immunosorbent assay. In addition, we show that rabbit Abs raised against the synthetic peptide of 12 aa were able to bind to the authentic E protein, and to neutralize DEN-2 virus in a plaque reduction assay.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1634111      PMCID: PMC7125935          DOI: 10.1016/0378-1119(92)90509-n

Source DB:  PubMed          Journal:  Gene        ISSN: 0378-1119            Impact factor:   3.688


  55 in total

Review 1.  Intrinsic and extrinsic factors in protein antigenic structure.

Authors:  J A Berzofsky
Journal:  Science       Date:  1985-09-06       Impact factor: 47.728

Review 2.  Epitope mapping of flavivirus glycoproteins.

Authors:  F X Heinz
Journal:  Adv Virus Res       Date:  1986       Impact factor: 9.937

3.  Nucleotide sequence of dengue 2 RNA and comparison of the encoded proteins with those of other flaviviruses.

Authors:  Y S Hahn; R Galler; T Hunkapiller; J M Dalrymple; J H Strauss; E G Strauss
Journal:  Virology       Date:  1988-01       Impact factor: 3.616

Review 4.  Flaviviridae.

Authors:  E G Westaway; M A Brinton; M C Horzinek; A Igarashi; L Kääriäinen; D K Lvov; J S Porterfield; P K Russell; D W Trent
Journal:  Intervirology       Date:  1985       Impact factor: 1.763

5.  Primer-directed enzymatic amplification of DNA with a thermostable DNA polymerase.

Authors:  R K Saiki; D H Gelfand; S Stoffel; S J Scharf; R Higuchi; G T Horn; K B Mullis; H A Erlich
Journal:  Science       Date:  1988-01-29       Impact factor: 47.728

Review 6.  The antigenic structure of proteins: a reappraisal.

Authors:  D C Benjamin; J A Berzofsky; I J East; F R Gurd; C Hannum; S J Leach; E Margoliash; J G Michael; A Miller; E M Prager
Journal:  Annu Rev Immunol       Date:  1984       Impact factor: 28.527

Review 7.  Immunoblotting and dot immunobinding--current status and outlook.

Authors:  H Towbin; J Gordon
Journal:  J Immunol Methods       Date:  1984-09-04       Impact factor: 2.303

8.  Identification of distinct antigenic determinants on dengue-2 virus using monoclonal antibodies.

Authors:  M K Gentry; E A Henchal; J M McCown; W E Brandt; J M Dalrymple
Journal:  Am J Trop Med Hyg       Date:  1982-05       Impact factor: 2.345

9.  A simple method for displaying the hydropathic character of a protein.

Authors:  J Kyte; R F Doolittle
Journal:  J Mol Biol       Date:  1982-05-05       Impact factor: 5.469

10.  Poliovirus neutralization epitopes: analysis and localization with neutralizing monoclonal antibodies.

Authors:  E A Emini; B A Jameson; A J Lewis; G R Larsen; E Wimmer
Journal:  J Virol       Date:  1982-09       Impact factor: 5.103

View more
  21 in total

1.  Replication-defective adenoviral vaccine vector for the induction of immune responses to dengue virus type 2.

Authors:  Smita Jaiswal; Navin Khanna; S Swaminathan
Journal:  J Virol       Date:  2003-12       Impact factor: 5.103

2.  Antibodies targeting dengue virus envelope domain III are not required for serotype-specific protection or prevention of enhancement in vivo.

Authors:  Katherine L Williams; Wahala M P B Wahala; Susana Orozco; Aravinda M de Silva; Eva Harris
Journal:  Virology       Date:  2012-04-25       Impact factor: 3.616

3.  Analysis of functional epitopes on the dengue 2 envelope (E) protein using monoclonal IgM antibodies.

Authors:  Z Jianmin; M L Linn; R Bulich; M K Gentry; J G Aaskov
Journal:  Arch Virol       Date:  1995       Impact factor: 2.574

4.  Epitope mapping of dengue 1 virus E glycoprotein using monoclonal antibodies.

Authors:  E Simantini; K Banerjee
Journal:  Arch Virol       Date:  1995       Impact factor: 2.574

5.  PrM- and cell-binding domains of the dengue virus E protein.

Authors:  S Wang; R He; R Anderson
Journal:  J Virol       Date:  1999-03       Impact factor: 5.103

6.  Identification of B-cell epitope of dengue virus type 1 and its application in diagnosis of patients.

Authors:  H C Wu; Y L Huang; T T Chao; J T Jan; J L Huang; H Y Chiang; C C King; M F Shaio
Journal:  J Clin Microbiol       Date:  2001-03       Impact factor: 5.948

7.  The development of therapeutic antibodies that neutralize homologous and heterologous genotypes of dengue virus type 1.

Authors:  Bimmi Shrestha; James D Brien; Soila Sukupolvi-Petty; S Kyle Austin; Melissa A Edeling; Taekyung Kim; Katie M O'Brien; Christopher A Nelson; Syd Johnson; Daved H Fremont; Michael S Diamond
Journal:  PLoS Pathog       Date:  2010-04-01       Impact factor: 6.823

8.  Generation and characterization of monoclonal antibodies against dengue virus type 1 for epitope mapping and serological detection by epitope-based peptide antigens.

Authors:  Yun-Ching Chen; Hsien-Neng Huang; Chin-Tarng Lin; Yi-Fang Chen; Chwan-Chuen King; Han-Chung Wu
Journal:  Clin Vaccine Immunol       Date:  2007-02-07

9.  Rapid displacement of dengue virus type 1 by type 4, Pacific region, 2007-2009.

Authors:  Dong-sheng Li; Wen Liu; Aurélie Guigon; Candice Mostyn; Richard Grant; John Aaskov
Journal:  Emerg Infect Dis       Date:  2010-01       Impact factor: 6.883

10.  Humoral immune responses of dengue fever patients using epitope-specific serotype-2 virus-like particle antigens.

Authors:  Wayne D Crill; Holly R Hughes; Mark J Delorey; Gwong-Jen J Chang
Journal:  PLoS One       Date:  2009-04-01       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.